Male contraception with LHRH agonists

作者: A. Belanger , F. Labrie , Y. Tremblay , A. Dupont , R. St-Arnaud

DOI: 10.1007/978-94-009-4910-2_6

关键词:

摘要: Stimulated by the unexplained lack of success LHRH and its agonists in treatment infertility men1, we investigated detail effect acute chronic administration these peptides on testicular functions experimental animals. We then made observation that short-term an agonist to adult male rats leads a loss LH prolactin receptors, as well decreased serum testosterone levels accompanied inhibition ventral prostate, seminal vesicle testis weight2–5. It is great interest that, among species so far studied, man most sensitive inhibitory with steroidogenesis5,6. In fact, while, rat, increases 5α-reductase activity formation 3α-androstanediol 5α-dihydrotestosterone, which can partially counteract production5,7, no such seen man, where androgen biosynthesis be completely inhibited medical castration thus achieved relatively easily secondary other than those related low circulating levels5,8,9.

参考文章(24)
Lacourciere Y, Raynaud Jp, Cusan L, Belanger A, Dupont A, Husson Jm, Labrie F, Laberge Jg, Monfette G, Fazekas At, Emond Jp, New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen. Clinical and Investigative Medicine. ,vol. 5, pp. 267- 275 ,(1982)
H. J. van der Molen, P. Polosa, R. D'Agata, M. B. Lipsett, Recent advances in male reproduction: molecular basis and clinical implications. Raven Press. ,(1983)
FERNAND LABRIE, ALAIN BÉLANGER, LIONEL CUSAN, CARL SEGUIN, GEORGES PELLETIER, PAUL A. KELLY, JERRY J. REEVES, FLEUR-ANGE LEFEBVRE, ANDRE LEMAY, YVES GOURDEAU, JEAN-PIERRE RAYNAUD, Antifertility Effects of LHRH Agonists in the Male Journal of Andrology. ,vol. 1, pp. 209- 228 ,(1980) , 10.1002/J.1939-4640.1980.TB00034.X
Claude Auclair, Paul A. Kelly, Fernand Labrie, David H. Coy, Andrew V. Schally, Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist or human chorionic gonadotropin Biochemical and Biophysical Research Communications. ,vol. 76, pp. 855- 862 ,(1977) , 10.1016/0006-291X(77)91579-0
Randy Linde, Gregory C. Doelle, Nancye Alexander, Fred Kirchner, Wylie Vale, Jean Rivier, David Rabin, Reversible Inhibition of Testicular Steroidogenesis and Spermatogenesis by a Potent Gonadotropin-Releasing Hormone Agonist in Normal Men New England Journal of Medicine. ,vol. 305, pp. 663- 667 ,(1981) , 10.1056/NEJM198109173051203
A. Belanger, C. Auclair, C. Seguin, P.A. Kelly, F. Labrie, Down-regulation of testicular androgen biosynthesis and LH receptor levels by an LHRH agonist: role of prolactin Molecular and Cellular Endocrinology. ,vol. 13, pp. 47- 53 ,(1979) , 10.1016/0303-7207(79)90075-3
F. Labrie, A. Dupont, A. Belanger, F.A. Lefebvre, L. Cusan, J.P. Raynaud, J.M. Husson, A.T.A. Fazekas, New Hormonal Therapy in Prostate Cancer: Combined Use of a Pure Antiandrogen and an LHRH Agonist Hormone Research in Paediatrics. ,vol. 18, pp. 18- 27 ,(1983) , 10.1159/000179775
F. Labrie, A. Dupont, A. Belanger, J. Emond, G. Monfette, Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 81, pp. 3861- 3863 ,(1984) , 10.1073/PNAS.81.12.3861
Réjean Carmichael, Alain Bélanger, Lionel Cusan, Carl Séguin, Simon Caron, Fernand Labrie, Increased testicular 5α-androstane-3α, 17β-diol formation induced by treatment with [D-Ser(TBU)6, des-Gly-NH210]LHRH ethylamide in the rat Steroids. ,vol. 36, pp. 383- 391 ,(1980) , 10.1016/0039-128X(80)90027-6